Definitions
Wiktionary
- n. A monoclonal antibody under investigation for the treatment of various cancers.
Etymologies
- -mab (Wiktionary)
Examples
“Pfizer Inc. said it ended a Phase III trial for its experimental lung-cancer drug called figitumumab.”
The Wall Street Journal: Pfizer Disappointed in Study Results for Two Drugs
“In the latest discontinuation, Pfizer was examining the effects of a compound with figitumumab as a second -/third-line treatment in patients with previously treated advanced non-small cell lung cancer.”
The Wall Street Journal: Pfizer Disappointed in Study Results for Two Drugs
“The company also said it would continue to study figitumumab in clinical trials for the potential treatment of prostate, breast and lung cancers.”
The Wall Street Journal: Pfizer Disappointed in Study Results for Two Drugs
“Pfizer ends study on potential lung cancer drugNEW YORK - Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness.”
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7
“- CP-751,871 or figitumumab, being developed by Pfizer Inc to target the insulin growth factor receptor or IGFR.”
“Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness ....”
“Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness .... news.”
WN.com - Articles related to Are your eyes puffy when you wake up in the morning?
“Pfizer ends study on potential lung cancer drug, committee says it won't meet treatment goal Pfizer ends study on potential lung cancer drugNEW YORK - Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness.”
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7
“Pfizer discontinues ADVIGO 1018 trial of figitumumab-erlotinib combination therapy for advanced NSCLC”
“Pfizer (NYSE: PFE) shares dropped after it discontinued its trials for figitumumab, a lung cancer drug, and announced that Phase 3 studies of its breast cancer drug Sutent did not meet their primary endpoints.”
Lists
‘figitumumab’ hasn't been added to any lists yet.
Tweets
Looking for tweets for figitumumab.
Comments
No comments yet...
Log in or sign up to get involved in the conversation. It's quick and easy.